Entries by april@madhedgefundtrader.com

October 30, 2024

Mad Hedge Technology Letter October 30, 2024 Fiat Lux   Featured Trade: (LACK OF AI ROCKS THE KOREAN HEAVYWEIGHT) (SAMSUNG), (SK HYNIX)

Lack Of AI Rocks The Korean Heavyweight

It’s not just about smartphones for Samsung anymore, their stalwart chip business is in full-blown crisis mode as they have been too slow to adapt to the artificial intelligence revolution. It shows that if a company is asleep at the wheel, how quickly and how far they can fall back. Samsung is Korea’s flagship tech

October 30, 2024

  (WE ARE EARLY IN THE AI GROWTH NARRATIVE – OPPORTUNITIES ARE AHEAD) October 30, 2024   Hello everyone.   Don’t listen to people who say the AI sector is stretched.  We are near the beginning of the journey, and there will be opportunities across the board, not just in Big Tech. Revenues related to

,

Take a Leap Into Leaps

How would you like to make 15 or 20 cents on every dollar invested? That is what we have been doing many times a month all year, and in fact, since Mad Hedge started 16 years ago. Would you like to make better than that, say 100% a year? How about 1,000% a year? Such

Trade Alert - (DHI) October 29, 2024 - BUY

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.

October 28, 2024

Mad Hedge Biotech and Healthcare Letter October 28, 2024 Fiat Lux   Featured Trade: (WHEN WALL STREET MET PHARMA) (PFE), (TSLA), (AAPL)

When Wall Street Met Pharma

If corporate America were a dinner party (and let's face it, sometimes it absolutely is), Pfizer (PFE) would be that guest who showed up fashionably late with an award-winning bourbon pecan pie during the pandemic, and is now being quietly judged for bringing Trader Joe's crackers to the latest soirée. The pharmaceutical giant, which briefly

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.